Steven J. Nicol

Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Metastatic Urothelial Cancer

Derek Raghavan, Michael A. Carducci, Ellis Levine et al. · Journal of Clinical Oncology · 2000 · 262 citations

Phase II Study of Pemetrexed for Second-Line Treatment of Transitional Cell Cancer of the Urothelium

Christopher J. Sweeney, Bruce J. Roth, Fairooz F. Kabbinavar et al. · Journal of Clinical Oncology · 2006 · 245 citations

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

William Small, Jordan Berlin, Gary M. Freedman et al. · Journal of Clinical Oncology · 2008 · 150 citations · Full text

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Nicholas Butowski, Susan M. Chang, Kathleen R. Lamborn et al. · Neuro-Oncology · 2011 · 77 citations · Full text

Surgical Oncology, Molecular Markers, Pharmacotherapy +18

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Mace L. Rothenberg, A. Sharma, Geoffrey R. Weiss et al. · Annals of Oncology · 1998 · 76 citations

Malignant Disease, Medicine, Clinical Trials +8